Filing Details
- Accession Number:
- 0001181431-12-010813
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-02-22 16:53:49
- Reporting Period:
- 2012-02-21
- Filing Date:
- 2012-02-22
- Accepted Time:
- 2012-02-22 16:53:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1401923 | Map Pharmaceuticals Inc. | MAPP | Pharmaceutical Preparations (2834) | 200507047 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1413822 | Anastasios Gianakakos | 2400 Bayshore Parkway, Suite 200 Mountain View CA 94043 | Svp & Chief Business Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-02-21 | 1,115 | $6.39 | 13,500 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-02-21 | 1,115 | $16.02 | 12,385 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2012-02-21 | 1,385 | $6.39 | 13,770 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-02-21 | 1,385 | $15.99 | 12,385 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2012-02-21 | 1,115 | $0.00 | 1,115 | $6.39 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2012-02-21 | 1,385 | $0.00 | 1,385 | $6.39 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 18,267 | 2017-05-01 | No | 4 | M | Direct | |
| 0 | 2017-05-01 | No | 4 | M | Direct |
Footnotes
- The sale of the reported shares is made pursuant to terms of 10b5-1 plan in effect at the time of sale of the shares.
- The range of price is from $15.87 to $16.29 per share. Full information regarding the number of shares sold at each separate price will be provided upon request by the SEC staff, or a security holder of the issuer.The range of price is from $15.87 to $16.29 per share. Full information regarding the number of shares sold at each separate price will be provided upon request by the SEC staff, or a security holder of the issuer.The range of price is from $15.87 to $16.29 per share. Full information regarding the number of shares sold at each separate price will be provided upon request by the SEC staff, or a security holder of the issuer.
- The option is exercisable as it vests: 25% of the total number of option shares vests and becomes exercisable on the first anniversary of the vesting commencement date. Thereafter, 1/48th of the total number of option shares becomes exercisable cumulatively on each monthly anniversary for 36 months so that the entire number of option shares becomes fully vested.
Billionaire Hedge Funds
